Join us for an insightful panel discussion on the critical challenges and opportunities in bringing pharmaceutical innovations to market. This dynamic session will explore key aspects of the drug commercialization journey, including regulatory strategy and market access considerations. Panelists will share their experiences in successfully launching new therapeutics while addressing evolving health care landscapes and stakeholder demands.

Panelists:  

• Alexander Brown, COO of Convergent Therapeutics
• Dr. Neil Bander, CSO, Co-Founder of Convergent Therapeutics
• Dr. Philip Kantoff, CEO, Co-Founder of Convergent Therapeutics
• Dr. Scott Tagawa, Professor of Medicine at Weill Cornell Medicine

Hosted by Brian Kelly, director of technology licensing at Weill Cornell Medicine

Register now.